查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470828

肿瘤消融市场：依技术、治疗、适应症分类 - 2024-2030 年全球预测

Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Irreversible Electroporation Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Indication - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年肿瘤消融市场规模为17.8亿美元，预计2024年将达20.1亿美元，2030年将达44.2亿美元，复合年增长率为13.85%。

肿瘤消融是一种微创外科手术，用于治疗体内各器官的肿瘤。这种治疗方法直接在肿瘤上使用热、冷或化学製剂来破坏癌细胞，而不需要大切口。常用于治疗肝癌、肾癌、骨癌、肺癌等。然而，这种技术对于大型肿瘤或靠近重要结构或器官的肿瘤并不总是有效，因为存在损坏这些区域的风险。此外，还可能发生出血、感染和周围组织损伤等併发症。需要继续研究来解决这些问题，包括提高消融技术的精度、开发更好的成像技术来指导手术以及加强对进行消融的医疗保健专业人员的培训。人工智慧和机器学习的进步可能会提高消融手术的准确性和结果。此外，全球癌症盛行率的不断上升以及对微创治疗的需求不断增加可能会推动肿瘤消融的采用。

主要市场统计
基准年[2023] 17.8亿美元
预测年份 [2024] 20.1亿美元
预测年份 [2030] 44.2亿美元
复合年增长率（%） 13.85%

腹腔镜消融术对需要治疗性微创手术的患者的快速利用

腹腔镜消融采用微创方法，使用射频、微波和雷射等多种能源来源，透过皮肤上的小切口进入并摧毁肿瘤。这种方法是需要更快恢復和侵入性较小的选择的患者的首选。当治疗中小型肿瘤以及需要精确应用消融能量时，它特别有利。经皮切除术涉及在电脑断层扫描或超音波等影像技术的引导下，将针头穿过皮肤直接插入肿瘤。最常见的类型是射频 (RF) 消融和微波消融。对于手术或腹腔镜检查难以触及肿瘤的患者，或不适合进行开放性手术的患者，此方法为首选。经皮方法是微创的，通常比传统手术需要更短的住院时间和更少的疼痛。手术切除术涉及透过开放性手术切除肿瘤，然后应用消融技术去除剩余的癌细胞。此方法主要用于肿瘤较大或位于其他方法难以切除的位置时。当完全切除肿瘤是可能且理想时，首选手术切除，并且当肿瘤被隔离且可触及时提供治癒的可能性。当由于肿瘤的大小或位置而无法使用腹腔镜或经皮方法时，也可以选择此方法。

适应症：加强肿瘤消融治疗肺癌的研究

肿瘤消融，特别是冷冻，在治疗小型早期乳癌方面已显示出前景。这种方法是传统手术的一种侵入性较小的治疗方法，可以减少恢復时间和美容影响。然而，其应用通常仅限于小肿瘤，其与标准乳癌手术相比的长期疗效仍在研究中。持续的临床试验对于更好地了解肿瘤消融在乳癌治疗中的治疗结果和潜在作用至关重要。射频消融（RFA）和冷冻消融等肿瘤消融方法可有效用于治疗较小的肾臟肿块。这些方法对于因其他健康问题而不适合手术或肿瘤较小且局部的患者特别有益。肿瘤消融在原发性和续发性肝癌的治疗上有明确的作用。 RFA 和微波消融 (MWA) 等技术很常用，特别是在无法进行手术切除的情况下。这些方法可有效实现局部肿瘤控制，提供潜在的生存益处，并且具有良好的安全性。肿瘤消融，特别是 RFA、冷冻消融和 MWA 的使用，正在成为非小细胞肺癌 (NSCLC) 的一种治疗选择。这些技术为治疗早期肺癌和其他原发部位肺部转移提供了一种微创方法。肿瘤消融在局部前列腺癌的治疗中越来越受到关注，冷冻消融和聚焦雷射消熔（FLA）等方法正在研究中。这些技术提供了一种有针对性的方法，旨在减少与传统治疗方法（如前列腺切除术和放射线治疗）相关的副作用，特别是尿失禁和勃起功能障碍。选择前列腺癌肿瘤消融患者需要仔细考虑肿瘤的大小、位置和侵袭性。

区域洞察

在强大的医疗基础设施和有利的报销政策的支持下，美洲先进肿瘤消融技术的采用率很高。该地区是开发和製造尖端消融设备的主要公司的所在地，为全球市场占有率做出了重大贡献。在亚太地区，由于医疗成本上升、癌症发生率上升以及患者和医疗保健提供者对微创治疗的认识不断提高，肿瘤消融的使用正在迅速增加。儘管亚太地区的产能正在扩大，但该市场仍处于追赶西方市场普及的技术和监管标准的过程中。儘管一些本土公司正在崛起，但该市场对寻求扩大地域影响力的全球公司也具有吸引力。欧洲、中东和非洲地区场景多样，西欧先进的医疗保健系统为肿瘤消融技术的采用提供了坚实的基础，这体现在坚实的法律规范上。在欧洲、中东和非洲地区营运的公司包括跨国公司和当地小型企业，它们在复杂的监管和市场条件下提供肿瘤消融疗法。

FPNV定位矩阵

FPNV定位矩阵对于评估肿瘤消融市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对肿瘤消融市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.肿瘤消融市场的市场规模和预测是多少？

2.在肿瘤消融市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.肿瘤消融市场的技术趋势和法规结构是什么？

4.肿瘤消融市场主要厂商的市场占有率如何？

5.进入肿瘤消融市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症发生率上升以及有效治疗方法的需求
      • 越来越多地转向微创手术切除肿瘤
      • 完善晚期癌症治疗的报销政策
    • 抑制因素
      • 肿瘤消融装置设计的复杂性
    • 机会
      • 全球肿瘤消融技术进展
      • 政府对肿瘤消融的有利核准
    • 任务
      • 对设备品质和安全的担忧
  • 市场区隔分析
    • 治疗：对需要微创手术的患者快速普及腹腔镜消融术
    • 适应症：加强使用肿瘤消融治疗肺癌的研究
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章肿瘤消融市场：依技术分类

  • 冷冻疗法
  • 高强度聚焦超音波
  • 不可逆电穿孔消融
  • 雷射组织内热消融
  • 微波消融
  • 射频消融术

第七章依治疗方式分類的肿瘤消融市场

  • 腹腔镜消融术
  • 经皮消融术
  • 手术消融

第八章按适应症分類的肿瘤消融市场

  • 乳癌
  • 肾癌
  • 肝癌
  • 肺癌
  • 摄护腺癌

第九章美洲肿瘤消融市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太肿瘤消融市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲肿瘤消融市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Medtronic)利用 FDA核准的OsteoCool 2.0 系统改善骨肿瘤治疗
    • BioTraceIO 基于超音波的 BioTraceIO 获得 FDA核准
    • FDA 授予 Francis Medical, Inc. 的蒸汽消融疗法 Vanquish 突破性称号
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-03252A5F927F

[180 Pages Report] The Tumor Ablation Market size was estimated at USD 1.78 billion in 2023 and expected to reach USD 2.01 billion in 2024, at a CAGR 13.85% to reach USD 4.42 billion by 2030.

Tumor ablation is a minimally invasive surgical method used for the treatment of tumors within various organs of the body. This procedure involves directing heat, cold, or chemical agents directly into a tumor to destroy cancer cells without necessitating large incisions. It is commonly employed in the treatment of liver, kidney, bone, and lung cancers, among others. However, the technique may not always be effective for larger tumors or for tumors that are close to critical structures or organs, as there is a risk of damaging these areas. Additionally, there may be complications such as bleeding, infection, or damage to the surrounding tissues. Addressing these concerns involves ongoing research into improving the precision of ablation techniques, developing better imaging technology to guide the procedures, and enhancing the training of medical professionals performing ablations. Advances in artificial intelligence and machine learning could lead to improved precision and outcomes of ablation procedures. Furthermore, the increasing prevalence of cancer worldwide and the rising demand for minimally invasive treatments are likely to drive the adoption of tumor ablation.

KEY MARKET STATISTICS
Base Year [2023] USD 1.78 billion
Estimated Year [2024] USD 2.01 billion
Forecast Year [2030] USD 4.42 billion
CAGR (%) 13.85%

Treatment: Exponential use of laparoscopic ablation for patients requiring minimally invasive surgery

Laparoscopic ablation involves the use of minimally invasive methods to access and destroy tumors using various energy sources, such as radiofrequency, microwave, or laser, through small incisions in the skin. This method is preferred for patients who require a minimally invasive option with a quicker recovery time. It is particularly advantageous for treating small to medium-sized tumors and where a precise application of ablation energy is needed. Percutaneous ablation involves the insertion of needles through the skin directly into the tumor, guided by imaging techniques such as CT scans or ultrasound. The most common types include radiofrequency (RF) ablation and microwave ablation. This approach is preferred for patients with tumors in locations difficult to reach by surgery or laparoscopy or who are not candidates for open surgery. The percutaneous method is minimally invasive and usually involves a shorter hospital stay and less pain compared to traditional surgery. Surgical Ablation entails the removal of the tumor through open surgery, followed by the application of ablation techniques to eliminate any remaining cancer cells. This method is primarily used for larger tumors or when tumors are located in positions that make other forms of ablation challenging. Surgical ablation is preferred when complete tumor resection is possible and desirable, offering a potential cure in cases where tumors are isolated and accessible. It is also chosen in situations where laparoscopic or percutaneous methods are not feasible due to the size or location of the tumor.

Indication: Increasing research in using tumor ablation for treating lung cancer

Tumor ablation, particularly cryoablation, has shown promise in the treatment of small, early-stage breast cancers. This method offers a less invasive alternative to traditional surgery, potentially reducing recovery times and cosmetic impact. However, its application is usually limited to small tumors, and the long-term efficacy compared to standard breast cancer surgeries is still under research. Ongoing clinical trials are essential to better understand the outcomes and potential roles of tumor ablation in breast cancer treatment. For small renal masses, tumor ablation techniques such as radiofrequency ablation (RFA) and cryoablation have been effectively used. These methods are particularly beneficial for patients who are not suitable for surgery due to other health concerns or for those with small, localized tumors. Tumor ablation has a well-established role in the management of primary and secondary liver cancers. Techniques such as RFA and microwave ablation (MWA) are commonly used, especially in cases where surgical resection is not possible. These methods can be effective in achieving local tumor control, offer potential survival benefits, and have a favorable safety profile. The use of tumor ablation, specifically RFA, cryoablation, and MWA, is emerging as a treatment option for non-small cell lung cancer (NSCLC). These techniques offer a minimally invasive approach to manage early-stage lung cancers or metastases to the lungs from other primary sites. Tumor ablation is gaining interest in the treatment of localized prostate cancer, with methods such as cryoablation and focal laser ablation (FLA) being explored. These techniques provide a targeted approach that aims to reduce side effects associated with more traditional treatments like prostatectomy and radiation therapy, particularly incontinence and erectile dysfunction. The selection of patients for tumor ablation in prostate cancer requires careful consideration of tumor size, location, and aggressiveness.

Regional Insights

In the Americas, there is a high adoption rate of advanced tumor ablation technologies, supported by strong healthcare infrastructure and favorable reimbursement policies. The region is home to leading companies that develop and manufacture cutting-edge ablation devices, contributing significantly to the global market share. The APAC region is witnessing rapid growth in the use of tumor ablation, driven by increasing healthcare expenditure, rising cancer prevalence, and growing awareness of minimally invasive treatments among patients and healthcare providers. Although APAC's production capabilities are expanding, the market is still in the process of catching up to the technical and regulatory standards prevalent in Western markets. Several local players are emerging, but the market is also attractive for global companies looking to expand their geographic presence. EMEA presents a diverse scenario where advanced healthcare systems in Western Europe offer a solid ground for the adoption of tumor ablation technologies mirrored by robust regulatory frameworks. Companies operating in the EMEA region are a mix of established global players and smaller, region-specific companies navigating the complex regulatory and market landscape to ensure the availability of tumor ablation therapies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tumor Ablation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tumor Ablation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tumor Ablation Market, highlighting leading vendors and their innovative profiles. These include Angiodynamics, Inc., Bioventus LLC., Boston Scientific Corp., BVM Medical Limited, Chongqing Haifu Medical Technology Co., Ltd., CONMED Corporation, CooperSurgical, Inc., Erbe Elektromedizin GmbH, IceCure Medical Ltd., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Mermaid Medical A / S, Smith & Nephew PLC, and Theraclion S. A..

Market Segmentation & Coverage

This research report categorizes the Tumor Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Cryoablation
    • High-Intensity Focused Ultrasound
    • Irreversible Electroporation Ablation
    • Laser Interstitial Thermal Ablation
    • Microwave Ablation
    • Radiofrequency Ablation
  • Treatment
    • Laparoscopic Ablation
    • Percutaneous Ablation
    • Surgical Ablation
  • Indication
    • Breast Cancer
    • Kidney Cancer
    • Liver Cancer
    • Lung Cancer
    • Prostate Cancer
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Tumor Ablation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tumor Ablation Market?

3. What are the technology trends and regulatory frameworks in the Tumor Ablation Market?

4. What is the market share of the leading vendors in the Tumor Ablation Market?

5. Which modes and strategic moves are suitable for entering the Tumor Ablation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer and need for effective treatments
      • 5.1.1.2. Increasing shift to minimally invasive surgeries to remove tumors
      • 5.1.1.3. Improvements in reimbursement policies for advanced cancer treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity of designing tumor ablation devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in tumor ablation technologies worldwide
      • 5.1.3.2. Favorable government approvals for tumor ablation
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with quality and safety of the device
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment: Exponential use of laparoscopic ablation for patients requiring minimally invasive surgery
    • 5.2.2. Indication: Increasing research in using tumor ablation for treating lung cancer
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Tumor Ablation Market, by Technology

  • 6.1. Introduction
  • 6.2. Cryoablation
  • 6.3. High-Intensity Focused Ultrasound
  • 6.4. Irreversible Electroporation Ablation
  • 6.5. Laser Interstitial Thermal Ablation
  • 6.6. Microwave Ablation
  • 6.7. Radiofrequency Ablation

7. Tumor Ablation Market, by Treatment

  • 7.1. Introduction
  • 7.2. Laparoscopic Ablation
  • 7.3. Percutaneous Ablation
  • 7.4. Surgical Ablation

8. Tumor Ablation Market, by Indication

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Kidney Cancer
  • 8.4. Liver Cancer
  • 8.5. Lung Cancer
  • 8.6. Prostate Cancer

9. Americas Tumor Ablation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tumor Ablation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tumor Ablation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Medtronic Elevates Bone Tumor Treatment with FDA-Approved OsteoCool 2.0 System
    • 12.3.2. BioTraceIO receives FDA Approval for Ultrasound-Based BioTraceIO
    • 12.3.3. FDA Grants Breakthrough Designation to Vanquish Water Vapor Ablation Therapy by Francis Medical, Inc.
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. TUMOR ABLATION MARKET RESEARCH PROCESS
  • FIGURE 2. TUMOR ABLATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TUMOR ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. TUMOR ABLATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. TUMOR ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TUMOR ABLATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TUMOR ABLATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL TUMOR ABLATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL TUMOR ABLATION MARKET SIZE, BY IRREVERSIBLE ELECTROPORATION ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL TUMOR ABLATION MARKET SIZE, BY IRREVERSIBLE ELECTROPORATION ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL TUMOR ABLATION MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL TUMOR ABLATION MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL TUMOR ABLATION MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL TUMOR ABLATION MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 94. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 99. CHINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. CHINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 105. INDIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 111. INDONESIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. INDONESIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 117. JAPAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 118. JAPAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 123. MALAYSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. MALAYSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 135. SINGAPORE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. SINGAPORE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 147. TAIWAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. TAIWAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 153. THAILAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. THAILAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 159. VIETNAM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. VIETNAM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 173. DENMARK TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. DENMARK TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 179. EGYPT TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. EGYPT TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 185. FINLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. FINLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 191. FRANCE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. FRANCE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 197. GERMANY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. GERMANY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 203. ISRAEL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. ISRAEL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 209. ITALY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. ITALY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 221. NIGERIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. NIGERIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 227. NORWAY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. NORWAY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 233. POLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. POLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 239. QATAR TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 240. QATAR TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 245. RUSSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. RUSSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 263. SPAIN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SPAIN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 269. SWEDEN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWEDEN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 281. TURKEY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. TURKEY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 296. TUMOR ABLATION MARKET, FPNV POSITIONING MATRIX, 2023